Dutch Cangrelor Registry

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

July 24, 2020

Study Completion Date

July 24, 2020

Conditions
STEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation MICoronary Artery Disease
Interventions
DRUG

Cangrelor

Cangrelor intravenous

Trial Locations (1)

8025AB

R.S. Hermanides, Zwolle

All Listed Sponsors
lead

Isala

OTHER

NCT04138641 - Dutch Cangrelor Registry | Biotech Hunter | Biotech Hunter